Obagi has reported positive results of 12-week study comparing CLENZIderm Serum Gel to a combination prescription benzoyl peroxide (BPO)/clindamycin product. In this multicenter, investigator-blind, randomized, split-face study,
Sanofi-aventis and Merck & Co. have signed an agreement under which Merck will sell its 50% interest in the companies’ current animal health joint venture, Merial, to Sanofi-aventis
Depomed has reported a revenue of $11.6m for the second quarter ended June 30, 2009, a increase in comparison with $6.3m for the second quarter ended June 30,
Natus Medical has reported revenue of $37.3 million for the second quarter ended June 30, 2009, a decrease in comparison to $39.9 million in the second quarter of
Endo Pharmaceuticals has reported an increase in total revenue by 22% to $373.1 million for the second quarter of 2009, in comparison to $306.2 million in the second
Pfizer and Medivation have initiated the phase 3 trial of the investigational drug dimebon (latrepirdine) in patients with Huntington disease. The international safety and efficacy trial, known as
The US Food and Drug Administration (FDA) has approved Colcrys to treat acute flairs in patients with gout (a recurrent and painful form of arthritis) and patients with
AstraZeneca has submitted a New Drug Application to the FDA, and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for an investigational drug – vandetanib
Anadys has received FDA clearance for its phase II protocol to study ANA598, in combination with pegylated interferonalpha and ribavirin, in hepatitis C patients. In the study, naive
XOMA has sealed a new $1.7 million subcontract by SRI International to produce novel antibody drugs against the virus that causes severe acute respiratory syndrome (SARS). Reportedly, the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.